中文 | English
Return
Total: 4757 , 1/476
Show Home Prev Next End page: GO
Author:( Bing ZHANG)

1.THE ROLE OF PROTEIN KINASE B IN THE APOPTOSIS OF GASTRIC CANCER CELLS INDUCED BY 12-O-TETRADECANOYLPHORBOL-1,3-ACETATE

Bing ZHANG

Acta Anatomica Sinica 1954;0(02):-

2.Study on clinical experience and strategy of prescription of great master of TCM YAN Zheng-hua

Bing ZHANG ; Jiarui WU

China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(06):-

3.Experience of YAN Zheng-hua in treating stomachache

Jiarui WU ; Bing ZHANG

China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(12):-

4.Experience of Professor YAN Zheng-hua in treating cold

Jiarui WU ; Bing ZHANG

China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(05):-

5.Epidemiological Characteristics of Anaphylactic Shock Caused by Qingkailing Injection

Jiarui WU ; Bing ZHANG

Traditional Chinese Drug Research & Clinical Pharmacology 1993;0(01):-

6.Medical Records Database and Epidemiological Characteristics of Adverse Reaction Caused by Compound Salviae Miltiorrhizae Injection

Jiarui WU ; Bing ZHANG

Traditional Chinese Drug Research & Clinical Pharmacology 1993;0(02):-

7.THE IMPLICATION OF PLC-?2 IN GASTRIC CANCER MGC80-3 CELLS TREATED BY TPA

Bing ZHANG ; Chun XIA

Acta Anatomica Sinica 2002;0(05):-

8.Study on Epidemiological Characteristics study of Adverse Reaction Induced by Chinese Medicine Injection Based on Database Establishment and Analysis

Jiarui WU ; Bing ZHANG

Traditional Chinese Drug Research & Clinical Pharmacology 1993;0(01):-

9.Epidemiological Characteristics of Adverse Reaction of Gegensu Injection Based on Database Analyze

Jiarui WU ; Bing ZHANG

Traditional Chinese Drug Research & Clinical Pharmacology 2000;0(06):-

10.Epidemiological characteristic of anaphylactic shock caused by Shuanghuanglian Injection

Jiarui WU ; Bing ZHANG

Chinese Traditional Patent Medicine 1992;0(05):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4757 , 1/476 Show Home Prev Next End page: GO